OTC Birth Control Pills: Options & Access Now

Over-the-Counter Birth Control: Opill’s FDA Approval and What It Means for Access February 29, 2024 A significant shift in reproductive healthcare occurred in July 2023 with the Food and Drug Administration’s (FDA) landmark approval of Opill, marking the first daily oral contraceptive pill available without a prescription in the United States. This decision promises to … Read more

HIV Drug Access Cuts: Ryan White & State Budget Limits

State HIV Programs Face Critical Funding Shortfalls, Threatening Patient Care A growing financial strain on state budgets is creating a ripple effect, severely impacting HIV programs across the nation, including those supported by the Ryan White HIV/AIDS Program. These cuts are forcing difficult decisions, from restricting patient eligibility to reducing the scope of vital services, … Read more

Child Tax Credit: State Relief Won’t Fully Offset Loss

Health Insurance Subsidies Lapse, States Step In to Mitigate Impact Washington D.C. – Millions of Americans face potential increases in health insurance costs as enhanced premium tax credits expired on January 1st, following Congressional inaction. The lapse occurred after failed Senate votes late last year and a lack of bipartisan agreement to extend the subsidies, … Read more

Health Insurance Consolidation: Trends & Market Share

ACA Marketplace Competition Surges Following Premium Tax Credit Expansion Washington D.C. – A newly released analysis reveals a significant shift in the landscape of health insurance competition, particularly within the individual market. While commercial health insurance remains largely consolidated across various coverage types, the Affordable Care Act (ACA) Marketplaces have experienced a notable influx of … Read more